
Sign up to save your podcasts
Or


Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer.
CME information and select publications here.
By Dr. Neil Love4.4
6363 ratings
Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer.
CME information and select publications here.

136 Listeners

316 Listeners

497 Listeners

31 Listeners

73 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

120 Listeners

44 Listeners

58 Listeners

3,349 Listeners

1,146 Listeners

45 Listeners

369 Listeners

57 Listeners

0 Listeners